搜尋結果
建銀國際下調康方生物(09926)目標價6% 反映盈測及生科股不確定性
infocast via Yahoo財經香港· 4 日前建銀國際發表報告,基於貼現現金流(DCF)估值,下調康方生物(09926)目標價6%,由 56.2 港元降至 53 港元,以反映較低的盈測以及圍繞中國主要生物科技股的不 ...
NRG Energy Shares Are Powered Up
Forbes· 4 日前Shares have gained more than 50% year to date. While the utilities sector has returned -1.97% so far this year, it has the ...